These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8370114)

  • 1. Preparation and pharmacological evaluation of N3-substituted thymidine derivatives as central depressants.
    Kimura T; Watanabe K; Tateoka Y; Kondo S; Ho IK; Yamamoto I
    Chem Pharm Bull (Tokyo); 1993 Jun; 41(6):1180-2. PubMed ID: 8370114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system depressant effects of N3-substituted derivatives of deoxyuridine in mice.
    Kimura T; Kuze J; Teraoka S; Watanabe K; Tateoka Y; Kondo S; Ho IK; Yamamoto I
    Biol Pharm Bull; 1996 Jan; 19(1):142-5. PubMed ID: 8820928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central depressant effects of N3-substituted 6-azauridines in mice.
    Koshigami M; Watanabe K; Kimura T; Yamamoto I
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2597-9. PubMed ID: 1725277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and central nervous system depressant effects of N3-substituted 2',3'-O-isopropylideneuridines.
    Yao CS; Kimura T; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Chem Pharm Bull (Tokyo); 1999 Dec; 47(12):1802-4. PubMed ID: 10748724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypnotic activity of N3-benzylthymidine on mice.
    Yamamoto I; Kimura T; Tateoka Y; Watanabe K; Ho IK
    Life Sci; 1987 Dec; 41(26):2791-7. PubMed ID: 3695807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypnotic activities of N3-benzyl and xylyl substituted arabinofuranosyluracil.
    Kimura T; Chun YS; Ikeda M; Kobana K; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Nucleic Acids Symp Ser; 1997; (37):229-30. PubMed ID: 9586083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central depressant activities of N3-allyluridine and N3-allylthymidine.
    Yamamoto I; Kimura T; Tateoka Y; Watanabe K; Ho IK
    Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):321-32. PubMed ID: 3738212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypnotic action of N3-substituted arabinofuranosyluracils on mice.
    Kimura T; Yao S; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Chem Pharm Bull (Tokyo); 2001 Jan; 49(1):111-3. PubMed ID: 11201214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 6-azauridine analogues possessing sedative and hypnotic effects.
    Kimura T; Watanabe K; Koshigami M; Miyamoto K; Kondo S; Yamamoto I
    Nucleic Acids Symp Ser; 1992; (27):199-200. PubMed ID: 1283907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and sedative-hypnotic effects of N3-allyl- and N1-allyl-5,6-substituted 2-thiouracil derivatives in mice.
    Dramiński M; Turski K; Tateoka Y; Kimura T; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Chem Pharm Bull (Tokyo); 1998 Sep; 46(9):1370-3. PubMed ID: 9775432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Syntheses and central depressant activity in mice of uracil derivatives. Studies on development of new sedative-hypnotics. II].
    Tateoka Y; Hiramura S; Usami N; Kimura T; Watanabe K; Yamamoto I
    Yakugaku Zasshi; 1992 Jul; 112(7):470-8. PubMed ID: 1432597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uridine receptor: discovery and its involvement in sleep mechanism.
    Kimura T; Ho IK; Yamamoto I
    Sleep; 2001 May; 24(3):251-60. PubMed ID: 11322706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potent depressant effects of N3-phenacyluridine in mice.
    Yamamoto I; Kuze J; Kimura T; Watanabe K; Kondo S; Ho IK
    Biol Pharm Bull; 1994 Apr; 17(4):514-6. PubMed ID: 8069259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nucleoside derivatives possessing sedative and hypnotic effects.
    Kimura T; Kuze J; Watanabe K; Yamamoto I; Ueda T; Katagiri N; Kaneko C; Tateoka Y; Kondo S
    Nucleic Acids Symp Ser; 1991; (25):95-6. PubMed ID: 1842113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-substituted oxopyrimidines and nucleosides: structure-activity relationship for hypnotic activity as central nervous system depressant.
    Yamamoto I; Kimura T; Tateoka Y; Watanabe K; Ho IK
    J Med Chem; 1987 Dec; 30(12):2227-31. PubMed ID: 3681892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological activities in mice of halogenated delta 9-tetrahydrocannabinol derivatives.
    Usami N; Kobana K; Yoshida H; Kimura T; Watanabe K; Yoshimura H; Yamamoto I
    Chem Pharm Bull (Tokyo); 1998 Sep; 46(9):1462-7. PubMed ID: 9775440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central effects of N-substituted derivatives of 2,6-dioxopiperidine in mice.
    Tateoka Y; Kimura T; Kamiyama H; Watanabe K; Yamamoto I; Ho IK
    Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):315-26. PubMed ID: 3187198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sedative and hypnotic activities of pyrimidine nucleoside derivatives.
    Kimura T; Teraoka S; Kuze J; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Nucleic Acids Symp Ser; 1993; (29):51-2. PubMed ID: 8247791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central effects of N-allyl,N'-methyl-barbital and N-allylmethyprylon in mice.
    Yamamoto I; Tateoka Y; Kimura T; Yamazaki F; Hamajima K; Watanabe K; Ho IK
    Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):191-9. PubMed ID: 2878477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the structure-activity relationship of allyl substituted oxopyrimidines searching for the novel antagonist or agonist of barbiturates to the sleep mechanism based on the uridine receptor theory--barbituric acid to uridine (part I)].
    Yamamoto I
    Yakugaku Zasshi; 2005 Jan; 125(1):73-120. PubMed ID: 15635282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.